Quantcast

Latest Ranbaxy Laboratories Stories

dd0772b310f9cf6dd7248b15c0b8292f1
2008-09-17 15:25:00

The U.S. Food and Drug Administration initiated a block on Tuesday of more than 30 generic drugs produced by Ranbaxy Laboratories Ltd. "“ India's biggest pharmaceutical company. The FDA said two of the pharmaceutical company's factories were in poor shape. The block includes generic versions of popular drugs including Cipro and cholesterol pill Zocor. Earlier this year, FDA inspections revealed violations that could be linked to contamination, allergic reactions and other complications...

2008-09-17 12:00:35

The FDA has issued two warning letters to India-based Ranbaxy Laboratories, and an import alert for generic drugs produced by the company's Dewas and Paonta Sahib plants in India. The warning letters identify the agency's concerns about deviations from US current Good Manufacturing Practice (cGMP) requirements at Ranbaxy's manufacturing facilities in Dewas and Paonta Sahib (including the Batamandi unit), in India. The problems at these two Ranbaxy plants relate to deficiencies in the...

2008-09-17 06:00:16

By Rita Rubin The Food and Drug Administration has issued an "import alert" to block approximately 30 generic drugs made by two plants in India from entering the USA, officials said Tuesday. "To date, we have seen no evidence of harm to consumers from drugs produced at these facilities," Douglas Throckmorton, deputy director of the Center for Drug Evaluation and Research at the FDA, told reporters. "Based on what we know today," he added, consumers shouldn't stop taking the drugs, which...

2008-09-16 15:00:38

The U.S. Food and Drug Administration has issued warning letters and an import alert for generic drugs produced by Ranbaxy Laboratories Ltd. of India. The warning letters identify the FDA's concerns about alleged deviations from U.S. Good Manufacturing Practice requirements at Ranbaxy's manufacturing facilities in Dewas and Paonta Sahib in India. "Because of the extent and nature of the violations, FDA today issued an import alert, under which U.S. officials may detain at the U.S. border,...

2008-09-05 12:00:27

Speaking before reporters at one of New Delhi's poshest hotels last month, Ranbaxy Laboratories (RANB.BO) CEO and Chairman Malvinder M. Singh was all smiles. Even though his family's company, India's largest drug manufacturer, had seen its profits plunge 91% from the previous quarter because of the volatile Indian currency, Singh had reason to be upbeat. Ranbaxy was in the process of finishing a merger with Tokyo-based Daiichi Sankyo (4568.T), a $4.6 billion deal [BusinessWeek.com, 6/11/08]...

2008-07-29 09:01:14

Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, Gurgaon, India, has announced that under an agreement with AstraZeneca Pharmaceuticals it has launched an authorized generic of Omeprazole 40mg capsules in the US healthcare system. Ranbaxy's Omeprazole 40mg is indicated for the treatment of acid-related disease, including gastric ulcer and Zollinger-Ellison syndrome. Jim Meehan, vice president of sales and distribution at Ranbaxy Pharmaceuticals, said: "We...

2008-07-28 12:01:07

GURGAON, India and PRINCETON, N.J., July 28 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India announced today that under an agreement with AstraZeneca Pharmaceuticals it has launched an authorized generic of Omeprazole 40 mg Capsules in the U.S. healthcare system. Omeprazole 40 mg is indicated for the treatment of acid-related disease, including gastric ulcer and Zollinger-Ellison syndrome. The most common...

2008-07-22 06:00:45

Research and Markets (http://www.researchandmarkets.com/research/70a734/india_pharmaceutic) has announced the addition of the "India Pharmaceuticals and Healthcare Report Q3 2008" report to their offering. This report provides independent forecasts and competitive intelligence on India's pharmaceuticals and healthcare industry. Multinationals continue to exhibit their interest in the market. For example, Israeli generic giant Teva is planning to use India for active pharmaceutical...

2008-07-19 09:00:17

By Alistair Dawber The increase in merger deals involving generic drug companies has continued apace after Israel's Teva Pharmaceuticals announced it was buying its American rival Barr, the fourth-biggest group in the sector, for $7.5bn (3.75bn). The friendly deal will combine the generalist group Teva with Barr, which specialises in female healthcare, giving the merged company more than 500 products and sales worth $11.9bn. Teva will pay $66.50 for each share, which represents a 32 per...

2008-06-19 09:00:42

DALLAS | Airlines executives are continuing to cut jobs and consider new fees on passengers as they battle high fuel prices. Executives from United Airlines gave more details on plans to shed up to 1,600 salaried jobs at an investors' conference in New York on Wednesday. Chief Financial Officer Jake Brace said United will also cut union jobs - pilots, flight attendants and mechanics - once the airline draws up a scaled-back flying schedule for fall and winter. Delta Air Lines Inc. said it...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related